|
Cortes, Lizette M; Mattapallil, Mary J; Silver, Phyllis B et al. (2008) Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice. Invest Ophthalmol Vis Sci 49:1946-56
|
|
Manjili, Masoud H; Kmieciak, Maciej; Keeler, Johanna (2006) Comment on ""Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma"". J Immunol 176:4511; author reply 4511-2
|
|
Zhao, Yangbing; Zheng, Zhili; Cohen, Cyrille J et al. (2006) High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation. Mol Ther 13:151-9
|
|
Restifo, Nicholas P; Rosenberg, Steven A (2005) Use of standard criteria for assessment of cancer vaccines. Lancet Oncol 6:3-4
|
|
Klebanoff, Christopher A; Gattinoni, Luca; Torabi-Parizi, Parizad et al. (2005) Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A 102:9571-6
|
|
Charo, Jehad; Finkelstein, Steven E; Grewal, Navrose et al. (2005) Bcl-2 overexpression enhances tumor-specific T-cell survival. Cancer Res 65:2001-8
|
|
Attia, Peter; Phan, Giao Q; Maker, Ajay V et al. (2005) Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J Clin Oncol 23:6043-53
|
|
Klebanoff, Christopher A; Khong, Hung T; Antony, Paul A et al. (2005) Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy. Trends Immunol 26:111-7
|
|
Borbulevych, Oleg Y; Baxter, Tiffany K; Yu, Zhiya et al. (2005) Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine design. J Immunol 174:4812-20
|
|
Dudley, Mark E; Wunderlich, John R; Yang, James C et al. (2005) Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 23:2346-57
|
Showing the most recent 10 out of 23 publications
